Home
Drugs
Oxaliplatin
Clinical Trials

Clinical Trials Related to Oxaliplatin

Related studies linked through entity extraction aliases.

A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer

Status: RECRUITING
Phase: PHASE2

Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the Pancreas

Status: COMPLETED
Phase: PHASE2

Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer

Status: RECRUITING
Phase: PHASE1

Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX

Status: NOT_YET_RECRUITING
Phase: PHASE2

Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

Status: RECRUITING
Phase: PHASE2

ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ Adenocarcinoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

Status: RECRUITING
Phase: PHASE3

Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer

Status: RECRUITING
Phase: PHASE2

Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer

Status: NOT_YET_RECRUITING
Phase: PHASE2

Gastric Cancer Organoids in the Screening of Neoadjuvant Drugs

Status: RECRUITING
Phase: N/A

M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negative, PD-L1 CPS<5, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma.

Status: RECRUITING
Phase: PHASE3

Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer

Status: NOT_YET_RECRUITING
Phase: PHASE2

Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.

Status: RECRUITING
Phase: PHASE2

A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors

Status: RECRUITING
Phase: PHASE1/PHASE2

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

Status: RECRUITING
Phase: PHASE1

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Status: RECRUITING
Phase: PHASE2

Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer

Status: RECRUITING
Phase: PHASE2

NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2